Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna(University of Milano-Bicocca), Giovanni Corrao(University of Milano-Bicocca), Cristina Bosetti(Mario Negri Institute for Pharmacological Research), Guıdo Grassı(University of Iowa), Alberico L. Catapano(University of Milan), Giuseppe Mancia(University of Milano-Bicocca), Lorenza Scotti(University of Milano-Bicocca), Carlo La Vecchia(University of Milan), Antonella Zambon(University of Milano-Bicocca)
Cited by 271
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k